Abstract:Depressive disorder is one of the most widespread forms of mental disorders which lead to a significant public health concern, such as disability, suicide, and so on. Its etiology remains vague but it is believed that depressive disorder is a multifactorial disease which is induced by the interaction of social, psychological, and biological factors. Thus, there is no clear and definite pathological theory could illustrate its mechanism independently until now, involving genetics, neuroimaging, neuroinflammation, neuroendocrine, and others. Comprehensive assessment to patients with depression is the starting point for a right diagnosis. History-taking of physical condition is as important as psychiatric interview and rational usage of scales would be beneficial for screening. There are many kinds of therapeutic measures for depressive patients nowadays, including general intervention, pharmacotherapy, psychotherapy, and physical therapy. For now, anti-depressants used in clinical practice is almost monoamine-based drugs while much more progress have been made in developing new antidepressant medications, like prototypical N-methyl-D-aspartate (NMDA) receptor antagonists, opioid agonists, gamma-aminobutyric acid (GABA(A)) receptors, and psychedelics. Once these novel drugs are proved to be practicable, it will create a historical evolution in the field of psychiatry. In addition, we advocate that measurement-based care (MBC) should run through the whole duration of treatment and goals of MBC in every stage are different. As brain projects in many countries are conducting in inspiring ways, we believe that our understanding about depressive disorder, of course, and other neuropsychiatric disorders will be better in the future.

Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications

Molecular, Functional, and Structural Imaging of Major Depressive Disorder

Major depressive disorder: hypothesis, mechanism, prevention and treatment

Translational Application of Neuroimaging in Major Depressive Disorder: a Review of Psychoradiological Studies

The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression

The Current Situation on Major Depressive Disorder in China: Research on Mechanisms and Clinical Practice

The roles of extracellular vesicles in major depressive disorder

Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression

Depressive Disorders: Mechanisms, Measurement and Management Introduction

Neuroimaging Advance in Depressive Disorder.

New insights into the neurobiological mechanisms of major depressive disorders

New and emerging treatments for major depressive disorder

Recent Progress in Mass Spectrometry-Based Metabolomics in Major Depressive Disorder Research

Energy Metabolism in Major Depressive Disorder: Recent Advances from Omics Technologies and Imaging.

Brain structural and functional changes in patients with major depressive disorder: a literature review

The neurobiology of depression: An integrated view

Pathogenesis of depression: Insights from human and rodent studies

Advances in biosensors for major depressive disorder diagnostic biomarkers

Research Progress on Neural Circuit Mechanisms of Depression

Research Progress on Mechanisms of Modulating Gut Microbiota to Improve Symptoms of Major Depressive Disorder

Unraveling Circuit Mechanisms of Depression Remission and Relapse Vulnerability